Isbn: 9783725852314 - acute and chronic heart failure: pathophysiology and new therapeutic developments (13 resultados)

HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Condición: New. New Book. Shipped from UK. Established seller since 2000.

Condición: New.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New.

Condición: As New. Unread book in perfect condition.

Condición: New. Print on Demand.

Condición: New. Print on Demand.

Condición: New. PRINT ON DEMAND.

Hardcover. Condición: new. Hardcover. The topic "Acute and Chronic Heart Failure: Pathophysiology and New Therapeutic Developments" was chosen because, despite the progress made in recent decades in the prevention and treatment of cardiovascular diseases, they remain the leading cause of death in both developed and developing countries, and heart failure (HF) is, in any case, the endpoint of the majority of cardiac pathologies. HF prevalence is progressively increasing worldwide, with HF with preserved ejection fraction (HFpEF) now exceeding 50% prevalence in HF cases. The published contributions are numerous and all are interesting. I would, however, like to emphasize the fact that a rapidly growing condition worldwide-insulin resistance with associated hyperinsulinemia-that is present in a large proportion of HF patients, particularly in HF patients with preserved or only slightly reduced ejection fraction, is still not treated as an independent risk factor, despite the large body of the literature demonstrating its role in numerous significant metabolic and cardiovascular abnormalities. Patients with insulin resistance, which will later progress to type 2 diabetes, may, over time, develop pathological remodeling of the left ventricle with, initially, diastolic dysfunction and, subsequently, also systolic dysfunction, which will lead to the development of HF. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Buch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The topic 'Acute and Chronic Heart Failure: Pathophysiology and New Therapeutic Developments' was chosen because, despite the progress made in recent decades in the prevention and treatment of cardiovascular diseases, they remain the leading cause of death in both developed and developing countries, and heart failure (HF) is, in any case, the endpoint of the majority of cardiac pathologies. HF prevalence is progressively increasing worldwide, with HF with preserved ejection fraction (HFpEF) now exceeding 50% prevalence in HF cases. The published contributions are numerous and all are interesting. I would, however, like to emphasize the fact that a rapidly growing condition worldwide-insulin resistance with associated hyperinsulinemia-that is present in a large proportion of HF patients, particularly in HF patients with preserved or only slightly reduced ejection fraction, is still not treated as an independent risk factor, despite the large body of the literature demonstrating its role in numerous significant metabolic and cardiovascular abnormalities. Patients with insulin resistance, which will later progress to type 2 diabetes, may, over time, develop pathological remodeling of the left ventricle with, initially, diastolic dysfunction and, subsequently, also systolic dysfunction, which will lead to the development of HF.…

Buch. Condición: Neu. Acute and Chronic Heart Failure | Pathophysiology and New Therapeutic Developments | Buch | Englisch | 2025 | MDPI AG | EAN 9783725852314 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.